Skip to main content
. 2010 Jan 13;115(19):3869–3878. doi: 10.1182/blood-2009-10-248997

Figure 2.

Figure 2

Clinical course of the 7 patients who underwent T-cell therapy. Timelines showing chronology of postrelapse treatment, disease status, histologic diagnoses of GVHD, and survival of all 7 patients who were treated for posttransplantation relapse with CD8+ mHAg-specific T-cell therapy.